Mar 29, 2017 - Gainers: TNXP +39%. NYMX +28%. VRTX +24%. INNL +18%. PACB +16%.Losers: ATOS -26%. RTTR -22%. DFFN -21%. CBIO -18%. SSH -17%.
May 03, 2017 - Despite topping Q1 revenue estimates, another figure in Pacific Biosciences quarterly report doomed its stock.
Sep 06, 2017 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
Dec 17, 2015 - PacBio has made significant strides in improving the accuracy and read lengths of the sequences produced by its machines, driving much stronger consumables utilization per machine.The new Sequel could
Mar 21, 2016 - The iShares Micro-Cap ETF's return is three times worse than the S&P 500 and the Morningstar Small Blend category.The fund's negative cash flow, historical, book value and sales growth provides a stro
Mar 08, 2016 - Meridian Funds Comments on Pacific Biosciences of California Inc., Stocks: PACB, Meridian Funds, release date:Mar 08, 2016
Apr 22, 2016 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2016 Earnings Conference Call April 21, 2016 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP of
May 05, 2016 - Illumina reported a shortfall of HiSeq sales in Q1.Management indicated various reasons but ruled out orders lost to competition.Pacific Biosciences on the other side reported a record Q1.
Aug 03, 2016 - [[AAOI]], [[ABTL]], [[ACAD]], [[ACHN]], [[ACXM]], [[AHS]], [[AHT]], [[AIRM]], [[AL]], [[ALNY]], [[AMBR]], [[AMH]], [[AMRS]], [[ANET]], [[ASYS]], [[ATRC]],
Aug 05, 2016 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2016 Earnings Conference Call August 4, 2016 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP, F